As shown in Fig. 7, compared to normal controls, MIAT was down-regulated in luminal B breast cancer tumor tissues which were inconsistent with our results, while S100A7, CCL5 and WT1-AS were up-regulated in luminal B breast cancer tumor tissues which were consistent with our results. The gene discussed is CCL5; the disease is breast carcinoma.